GeneCraft Inc. is a pre-clinical-stage biotech company that was founded in 2020. The company is dedicated to improving treatment and clinical outcomes for patients through gene therapy that harnesses the innate oncogene defense system. The industries it operates in include Biopharma and Biotechnology. GeneCraft recently secured a KRW10.00B Series A investment on 15 January 2024. The investors involved in this round of funding include Seoul National University Technology Holdings, Cosine Investment, and InfoBank. This significant investment and support from these established investors indicate the promising potential of GeneCraft to make a substantial impact in the biotech industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | KRW10.00B | 3 |
|
15 Jan 2024 |
No recent news or press coverage available for GeneCraft Inc..
,-a-subsidiary-of-Sabai-Global-logo.jpg){kind=logo}
We care about your data, and we'd love to use cookies make your experience better.
